Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-α-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 9, 1997, Pages 919-931

  Koeppe, Robert A ^a   Frey, Kirk A ^a   Kume, Akito ^a   Albin, Roger ^a,b   Kilbourn, Michael R ^a   Kuhl, David E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

(+) 11C dihydrotetrabenazine; Equilibrium analysis; Monoamine vesicular transporter; Positron emission tomography; Tracer kinetics; VMAT2

Indexed keywords

CARBON 11; CARRIER PROTEIN; DIHYDROTETRABENAZINE; MONOAMINE; TRACER;

ADULT; ANALYTIC METHOD; ARTICLE; BRAIN; COMPARTMENT MODEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LIGAND BINDING; MEMBRANE TRANSPORT; MEMBRANE VESICLE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0030869724     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199709000-00001     Document Type: Article

References (32)

1. Alpert NM, Eriksson L, Chang JY, Bergstrom M, Litton JE, Correia JA, Bohm C, Ackermann RH, Taveras JM (1984) Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography. J Cereb Blood Flow Metab 4: 28-34
2. Bevington PR (1969) Data Reduction and Error Analysis for the Physical Sciences, New York, McGraw-Hill, pp 232-241
3. 18F-cyclofoxy opiate receptor imaging with PET. J Cereb Blood Flow Metab 1989; (Suppl 1)9:S203
4. 11C]tetrabenazine to vesicular monoamine transporters in mouse brain. Life Sci 51;593-600
5. Farde L, Hakan H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231:258-261
6. 11C-raclopride. Psychopharmacology 92:278-284
7. Frey KA, Ehrenkaufer RLE, Beaucage S, Agranoff BW (1984) Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor. J Neurosci 5:421-428
8. 11C]flumazenil binding to human benzodiazepine receptors. J Cereb Blood Flow Metab (Suppl 1)13:S794
9. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE (1991) Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 30:663-672
10. Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE (1996) Reduction of presynaptic monoaminergic vesicles in the striata of Parkinsonian patients and in normal human aging. Ann Neurol 40:873-884
11. 11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab 12:147-154
12. 11C]dihydrotetrabenazine and PET. Ann Neurol 40:885-892
13. Henry J-P, Scherman D (1989) Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem Pharmacol 38:2395-2404
14. 11C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 24:197-199
15. D with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat. J Cereb Blood Flow Metab 11:529-544
16. Kilbourn MR (1994) PET radioligands for vesicular monoamine transporters. Med Chem Res 5:113-126
17. Kilbourn MR, Lee L, Vander Borght T, Jewett D, Frey K (1995) Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur J Pharmacol 278:249-252
18. Kish SJ, Robaitaille Y, El-Awar M, Clark B, Schut L, Ball MJ, Young LT, Currier R, Shannak K (1992) Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology 42:1573-1577
19. 11C]dihydrotetrabenazine by dynamic PET: measurement of the vesicular monoamine transporter. J Cereb Blood Flow Metab 16: 1288-1299
20. Koeppe RA, Frey KA, Vander Borght TM, Kilbourn MR, Jewett DM, Lee LC, Kuhl DE (1995) Kinetic evaluation of α-[C-11]dihydrotetrabenazine (DTBZ): a PET ligand for assessing the vesicular monoamine transport. J Nucl Med 36:118P
21. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735-744
22. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747
23. Minoshima S, Koeppe RA, Mukhopadhyay S, Jewett D, Kuhl DE, Kilbourn MR, Frey KA (1994) Equilibrium measurement of [C-11]raclopride distribution volume in the brain using a continuous infusion technique. J Nucl Med 35:140P
24. Naudon L, Leroux-Nicollet I, Costentin J (1994) Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neurosci Lett 173:1-4
25. 11C]Ro 15-1788 to central type benzodiazepine receptors in human brain: Quantitative evaluation by PET. J Cereb Blood Flow Metab 8:304-313
26. 11C]-labelled RO 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 19:609-622
27. 11C Ro 15-1788 binding to the human neocortex using positron emission tomography. Hum Psychopharmacol 4:21-31
28. Shinotoh H, Iyo M, Yamada T, Inoue O, Suzuki K, Itoh T, Fukuda H, Yamasaki T, Tateno Y, Hirayama K (1989) Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography. Psychopharmacology (Berl) 99:202-207
29. Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hasimoto K, Tateno Y, Ikehira H (1986) Visualization of specific binding sites of benzodiazepine. J Nucl Med 27:1593-1599
30. Vander Borght TM, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA (1995a) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294:577-583
31. 3H]Methoxytetrabenazine a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience 68:955-962
32. Wilson JM, Carroll ME, Kish SJ (1996) The vesicular monoamine transporter, in contrast to the dopamine transport, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16:3507-3510